Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
270.9 USD | +0.76% | -1.62% | -5.94% |
Mar. 09 | Amgen Presents New Research on Otezla at AAD 2024 | CI |
Mar. 06 | Amgen Keeps Q2 Dividend at $2.25 a Share, Payable June 7 to Stockholders of Record May 17 | MT |
Financials (USD)
Sales 2024 * | 33.01B | Sales 2025 * | 34.06B | Capitalization | 144B |
---|---|---|---|---|---|
Net income 2024 * | 6.12B | Net income 2025 * | 7.57B | EV / Sales 2024 * | 5.78 x |
Net Debt 2024 * | 46.64B | Net Debt 2025 * | 41.16B | EV / Sales 2025 * | 5.44 x |
P/E ratio 2024 * |
23.5
x | P/E ratio 2025 * |
18.2
x | Employees | 26,700 |
Yield 2024 * |
3.42% | Yield 2025 * |
3.7% | Free-Float | 99.63% |
Latest transcript on Amgen Inc.
1 day | +0.76% | ||
1 week | -1.04% | ||
Current month | -1.07% | ||
1 month | -4.51% | ||
3 months | -1.65% | ||
6 months | +3.90% | ||
Current year | -5.94% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 61 | 06-05-31 |
Peter Griffith
DFI | Director of Finance/CFO | 65 | 19-10-22 |
Chief Tech/Sci/R&D Officer | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Holley
BRD | Director/Board Member | 67 | 17-02-02 |
Ellen Kullman
BRD | Director/Board Member | 68 | 16-10-13 |
Robert Williams
BRD | Director/Board Member | 75 | 14-10-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.84% | 0 M€ | 0.00% | - | |
7.63% | 0 M€ | 0.00% | - | |
5.08% | 108 M€ | +8.80% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 270.9 | +0.76% | 3,608,491 |
24-03-15 | 268.9 | -0.98% | 8,795,786 |
24-03-14 | 271.5 | -1.61% | 2,370,492 |
24-03-13 | 276 | -0.20% | 1,641,024 |
24-03-12 | 276.5 | +0.43% | 1,738,941 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.94% | 144B | |
+30.83% | 679B | |
+30.96% | 589B | |
+0.01% | 381B | |
+15.18% | 314B | |
+11.39% | 308B | |
+0.78% | 212B | |
-6.09% | 210B | |
-2.92% | 203B | |
-3.72% | 158B |